333360-66-0

Basic information

• Product Name: (2S,3R,4R,5S,6R)-2-(3-(4-hydroxybenzyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
• Synonyms: (2S,3R,4R,5S,6R)-2-(3-(4-hydroxybenzyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
• CAS NO: 333360-66-0
• Molecular Weight: 360.407
• Mol File: 333360-66-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (2S,3R,4R,5S,6R)-2-(3-(4-hydroxybenzyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3R,4R,5S,6R)-2-(3-(4-hydroxybenzyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol(333360-66-0)
• EPA Substance Registry System: (2S,3R,4R,5S,6R)-2-(3-(4-hydroxybenzyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol(333360-66-0)

Safety Data

• Hazardous Substances Data: 333360-66-0(Hazardous Substances Data)

Upstream product

• 912917-86-3 1-Methyl-4-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranos-1-yl)-2-(4-acetoxy-benzyl)-benzene 
• 108-95-2 phenol 
• 21900-41-4 5-bromo-2-methylbenzoyl?chloride 
• 103-73-1 Phenetole 
• 333361-21-0 5-bromo-2-methyl-4'-hydroxydiphenylmethane 
• 912917-84-1 (3R,4S,5S,6R)-2-(3-(4-hydroxybenzyl)-4-methylphenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol 
• 79669-49-1 5-bromo-2-methylbenzoic acid 
• 1221506-24-6 (5-bromo-2-methylphenyl)(4-ethoxyphenyl)methanone 
• 1360568-87-1 (5-bromo-2-methylphenyl)(4-hydroxyphenyl)methanone 
• 1360568-88-2 4-bromo-2-(4-(methoxymethoxy)benzyl)-1-methylbenzene 
• 1360568-89-3 (3R,4R,5S,6R)-2-(3-(4-hydroxybenzyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 32469-28-6 (3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one 
• 90-80-2 D-Glucono-1,5-lactone 

Downstream Products

• 892486-47-4 1-methyl-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-4-(β-D-glucopyranos-1-yl)-benzene 
• 1360569-32-9 (2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-(4-methyl-3-(4-((1-(trifluoromethyl)cyclopropyl)methoxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1360569-33-0 (2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-(4-methyl-3-(4-((1-(trifluoromethyl)cyclobutyl)methoxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1360569-34-1 (2S,3R,4R,5S,6R)-2-(3-(4-((4,4-difluoro-1-methylcyclohexyl)methoxy)benzyl)-4-methylphenyl)6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 

Relevant articles and documents

CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS

The invention relates to the cycloalkyl methoxybenzyl phenyl pyran derivatives as Sodium dependent glucose co transporter (SGLT) inhibitors, particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 with them, and processes for preparing them.

Glucopyranosyl-substituted benzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture

Glucopyranosyloxy-substituted benzyl-benzene derivatives of the general formula I where the groups groups R1, R2, R3a, R3b, R4, R5, R6, X and R7a, R7b, R7c are defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.

Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture

Glucopyranosyloxy-substituted (heteroaryloxy-benzyl)-benzene compounds of the general formula I where the groups R1 to R6 as well as R7a, R7b, R7c are defined according to claim 1, including the tautomers, the stereoisomers thereof, the mixtures thereof and the salts thereof. The compounds according to the invention are suitable for the treatment of metabolic disorders.